Vivos (RDGL) EPS (Basic) Growth (3y) (2013 - 2025)
Powered by 
Analysis
Vivos (RDGL) EPS (Basic) Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 17.98% |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5.86% |
| Sep 30, 2025 | -13.08% |
| Jun 30, 2025 | 14.66% |
| Mar 31, 2025 | 2.94% |
| Dec 31, 2024 | -65.90% |
| Sep 30, 2024 | -48.70% |
| Jun 30, 2024 | 39.61% |
| Mar 31, 2024 | -14.36% |
| Dec 31, 2023 | -29.11% |
| Sep 30, 2023 | -46.05% |
| Jun 30, 2023 | -38.71% |
| Mar 31, 2023 | 28.89% |
| Dec 31, 2022 | 11.30% |
| Sep 30, 2022 | 41.02% |
| Jun 30, 2022 | -25.57% |
| Mar 31, 2022 | -125.41% |
| Dec 31, 2021 | -26.19% |
| Sep 30, 2021 | 79.51% |
| Jun 30, 2021 | 56.34% |
| Mar 31, 2021 | 58.64% |